Metraipolis › archive › dc_905be5f2be77

The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathway — Europe PMC PMID:42776394

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42776394
DOI
10.1186/s43556-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-07T22:52:36.725Z
SHA-256 of the archived text
d662db160c86cf429c69cf738e696d09736c16cdbe657f453706964361126ac9
Stable URL of this page
https://metraipolis.com/documento/dc_905be5f2be77

How to cite

The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathway — Europe PMC PMID:42776394 — Europe PMC (en), https://europepmc.org/article/MED/42776394 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_905be5f2be77 (Metraipolis archive dc_905be5f2be77, sha256 d662db160c86cf429c69cf738e696d09736c16cdbe657f453706964361126ac9)
BibTeX
@misc{dc905be5f2be77,
  title = {The DCBLD2 super-enhancer drives colorectal cancer progression through FOSL2/JUND-mediated activation of the CD146/AKT/TNFRSF6B pathway — Europe PMC PMID:42776394},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42776394},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_905be5f2be77; sha256 d662db160c86cf429c69cf738e696d09736c16cdbe657f453706964361126ac9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42776394. Agents can read the archived copy with the MCP tool read_document.